This is a very exciting time to be joining the Pistoia Alliance. The global healthcare and life sciences industries are undergoing huge changes, with regulators, payers, providers and patients all demanding more value.
Wilmington, DE (PRWEB) October 13, 2015
The Pistoia Alliance has appointed Dr Steve Arlington as its new President. Steve joins as the Pistoia Alliance continues to drive to increase the organization’s impact on the global innovation landscape in life sciences R&D.
The non-profit Pistoia Alliance is focusing its vision and expanding its work in supporting pre-competitive collaboration in the life sciences sector. Steve brings new leadership to an already active organization with a growing number of sector-wide members, collaborations and a remit to continue the transformation of the life sciences industry through innovative new approaches.
Steve previously was the Global Lead Partner, Pharmaceuticals and Life Sciences consulting at PwC where he was responsible for leadership and growth of the global team. He also headed the influential pharma thought leadership series Pharma 2005, Pharma 2010 and Pharma 2020. Steve began his career in research at Smith Kline, and has held senior roles at Unipath, PA Consulting and IBM. He has also led a biotech business and served on a number of supervisory boards.
Commenting on his appointment, Steve, said: “This is a very exciting time to be joining the Pistoia Alliance. The global healthcare and life sciences industries are undergoing huge changes, with regulators, payers, providers and patients all demanding more value. Today, there is a need for a marked departure from the traditional models, and technology and innovative applications of technology across the whole health, pharma and life sciences ecosystem will become more important than ever before.
“The Pistoia Alliance is well placed to be at the forefront of this through its cross–industry network. Having already made an impact through a number of initiatives including HELM and CSCS, I look forward to championing new initiatives to support the life sciences sector globally.”
Michael Braxenthaler, outgoing President of the Pistoia Alliance said: “I am delighted to welcome Steve to the Pistoia Alliance. He has a wealth of experience in the life sciences sector, and this will be key to transforming how the sector operates. I am confident that under Steve’s leadership the Pistoia Alliance will continue to grow and demonstrate industry leadership.”
About the Pistoia Alliance
The Pistoia Alliance is a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D. Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles. Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community. For further information about the Pistoia Alliance please visit our website: http://www.pistoiaalliance.org/.